Table 3

Univariate Predictors of Events

HR (95% CI)p Value
Clinical characteristics
 Age (yrs)1.0 (0.99–1.0)0.12
 Male gender 0.86 (0.34–2.2)0.75
 Obesity0.71 (0.24–2.0)0.52
 Diabetes0.85 (0.32–2.3)0.74
 Hypercholesterolemia1.4 (0.62–3.0)0.45
 Hypertension0.62 (0.28–1.3)0.24
 Family history of CAD1.3 (0.61–2.9)0.47
 Smoking1.7 (0.77–3.6)0.19
 Previous revascularization1.4 (0.62–3.1)0.63
 Previous infarction1.5 (0.67–3.2)0.92
 EuroSCORE value1.1 (0.99–1.3)0.08
Medical therapy
 ACE inhibitors0.65 (0.28–1.6)0.34
 Nitrates1.0 (0.36–3.0)0.94
 Beta-blockers1.4 (0.61–3.0)0.46
 Aspirin1.8 (0.80–4.0)0.15
 Statins0.86 (0.40–1.9)0.70
MSCT characteristics
 Total Agatston score1.1 (1.0–1.1)0.06
 Presence of coronary plaques on MSCT8.0 (1.1–59)0.04
 Abnormal coronary arteries, no obstructive CAD (as compared with no CAD)2.7 (0.32–22)0.36
 Abnormal coronary arteries, obstructive CAD (as compared with no CAD)22 (2.9–166)0.003
 Abnormal coronary arteries, no obstructive CAD in LM/LAD3.1 (0.39–25)0.29
 Abnormal coronary arteries, obstructive CAD in LM/LAD36 (4.7–276)0.0006
 Segments with plaques1.3 (1.1–1.4)0.0005
 Segments with obstructive plaques1.8 (1.5–2.1)<0.0001
 Segments with noncalcified plaques1.1 (0.78–1.6)0.43
 Segments with mixed plaques1.5 (1.3–1.9)0.0002
 Segments with calcified plaques1.1 (0.98–1.3)0.1

CI = confidence interval; HR = hazard ratio; other abbreviations as in Tables 1and 2.

  • Ratio per segment.